Atherosclerosis: process, indicators, risk factors and new hopes - Test2 - elhamkhani - TriplyDB

Atherosclerosis: process, indicators, risk factors and new hopes

Atherosclerosis: process, indicators, risk factors and new hopes

http://www.wikidata.org/entity/Q26822655

about

Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy Synergism of Chinese Herbal Medicine: Illustrated by Danshen Compound The Role of Endoplasmic Reticulum Stress and Unfolded Protein Response in Atherosclerosis Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis Assessing cardiovascular risk in hepatitis C: An unmet need Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population.Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial Ezetimibe Attenuates Atherosclerosis Associated with Lipid Reduction and Inflammation Inhibition.Increased Subsequent Risk of Peptic Ulcer Diseases in Patients With Bipolar Disorders.A Highly Expressed Human Protein, Apolipoprotein B-100, Serves as an Autoantigen in a Subgroup of Patients With Lyme Disease.Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: decreased CIMT, reduced plasma lipid levels, and decreased blood pressure.Pre-treatment with simvastatin prevents the induction of diet-induced atherosclerosis in a rabbit model.A Note on Fatty Acids Profile of Meat from Broiler Chickens Supplemented with Inorganic or Organic Selenium.Abdominal adipose tissue thickness measured using magnetic resonance imaging is associated with lumbar disc degeneration in a Chinese patient population.Changes in transcriptome of macrophages in atherosclerosis.Chronic hepatitis C virus infection: a new modifiable cardio-metabolic risk factor?Arterial Thickness and Immunometabolism: The Mediating role of Chronic Exercise.Microstructure-based biomechanics of coronary arteries in health and disease.The Case for Endothelial Preservation via Pressure-Regulated Distension in the Preparation of Autologous Saphenous Vein Conduits in Cardiac and Peripheral Bypass Operations.In Vivo and In Vitro Analysis in Coronary Artery Disease Related to Type 2 Diabetes.Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis.The cytoprotective effects of Δ-17 fatty acid desaturase on injured HUVECs and its underlying mechanism.Cytoprotective Effects and Mechanisms of Δ-17 Fatty Acid Desaturase in Injured Human Umbilical Vein Endothelial Cells (HUVECs).Effects of Antiepileptic Drugs on the Carotid Artery Intima-Media Thickness in Epileptic Patients.Oxidative Stress in Cardiovascular Diseases: Involvement of Nrf2 Antioxidant Redox Signaling in Macrophage Foam Cells Formation.Metformin-induced activation of AMPK inhibits the proliferation and migration of human aortic smooth muscle cells through upregulation of p53 and IFI16.Comparison of Pioglitazone and Metformin Efficacy against Glucocorticoid Induced Atherosclerosis and Hepatic Steatosis in Insulin Resistant Rats.Risk of Microangiopathy in Patients with Epilepsy under Long-term Antiepileptic Drug Therapy.Serum Proteomic Profiling to Identify Biomarkers of Premature Carotid Atherosclerosis.Thiol/Disulfide Balance in Patients with Familial Hypercholesterolemia.

P2860

Q26738281-BA71A045-7799-4DFA-B13C-0B35E1D07C3F Q26748772-23C74F66-4690-48C9-A361-CEE83E3143D7 Q26769783-2ACF5E3F-4343-4CD6-8340-731CD724C9E7 Q26783046-A48FC6D0-E01F-45E7-9FAA-9075AD2F6901 Q26784258-0CC8335F-8B74-411C-9C60-48FE3019D442 Q28393421-C85D8368-815A-41DF-98D9-83F027F080B4 Q33560682-6EB9D1D8-8A97-484B-8923-4E517BB62360 Q33752266-650766B8-B2A7-44BD-93F7-ABF898782FAC Q35777029-50E01AFB-7FA5-47B6-99A7-78F94BD7795D Q35837416-A1D67DA4-357D-4E39-8F23-32518A8AFD72 Q36153453-B0D9FDD1-BE8B-4F43-83B2-0B2F9CCA7811 Q36250228-C48D472B-8A5F-401F-89E9-BDF7457C356C Q36837562-0DC2D621-D06F-46F5-A37B-EB39835A2B7A Q37581629-52B9E02C-B5B4-42E7-9CA9-00622FEE42C7 Q37615076-028B06DD-67D6-436E-A0CA-238028A941B6 Q37696078-9D9B10F4-92CA-40F0-92A8-200BCD0F675C Q38479492-DDD079BF-F875-4712-A9CC-086B8F57B31F Q38638110-32884687-49B6-4403-BF36-C9B227BEF207 Q38714345-69304AAD-1A8C-4E5D-A9F1-168974258C46 Q38810175-DF9C0D9C-E089-41A9-A1A1-5A1FB0D6AA6E Q41146197-52FF0DC6-02A7-4A84-862A-1BCB750C017C Q41487994-1E8E5364-FD8A-4658-91C2-A8D5297F8CC2 Q42052307-94C52D28-69D4-4271-AE1C-A23434474A3A Q42134999-D4FCF6AB-9D3E-4BB9-9D4A-BE2B1F14C38D Q42292116-4AD4891A-A1A7-44FD-8A73-ADF6F7AC14B6 Q42646136-75960BDD-E12E-4D4D-8185-DE05F4A5E1F5 Q46266568-BB6D41E6-C5B2-4D5B-8D43-3F137F43AE16 Q47246258-B5F90618-C772-4180-BF4F-3BDA00FD1AD5 Q48002814-7033CFD5-D3A0-42F9-840D-2EF66169FE81 Q55037428-CD6F4272-A0FC-4651-BAE0-7B52D302C562 Q55368085-7FD1D4FF-2F7B-4EF7-897E-6E0DF908A0BB Q55621802-32692279-A732-4F48-8122-AA6D0832A02E

P2860

Atherosclerosis: process, indicators, risk factors and new hopes

http://www.wikidata.org/entity/Q26822655

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Atherosclerosis: process, indicators, risk factors and new hopes

@ast

Atherosclerosis: process, indicators, risk factors and new hopes

@en

Atherosclerosis: process, indicators, risk factors and new hopes

@nl

type

label

Atherosclerosis: process, indicators, risk factors and new hopes

@ast

Atherosclerosis: process, indicators, risk factors and new hopes

@en

Atherosclerosis: process, indicators, risk factors and new hopes

@nl

prefLabel

Atherosclerosis: process, indicators, risk factors and new hopes

@ast

Atherosclerosis: process, indicators, risk factors and new hopes

@en

Atherosclerosis: process, indicators, risk factors and new hopes

@nl

P1433

Q26822655-31FF31C2-CB1B-4516-AED6-06398C8DF5CF

P1476

Q26822655-A7B4C5A9-D7EA-4723-B7BB-7CF7C514CC51

P2093

Q26822655-1640B495-4834-4B5D-8D69-D490D3D8976B

Q26822655-5806F60A-EBFA-4EE9-A445-51753C45D606

Q26822655-64B75A0A-4CC4-47F6-B8BB-88FF70191EF6

Q26822655-6D2A35AF-D48B-4B3B-A2AF-A16A3851BAC2

Q26822655-F006133A-8EA3-4025-B3AE-745196E199F8

P2860

Q26822655-024E980C-9034-4616-85CC-06B553C9B1F7

Q26822655-03925187-8FAB-4A62-84B7-465AA1C1B1C6

Q26822655-0674B8A9-277F-447A-9E7B-7A9A84A5616E

Q26822655-07564C72-8ADA-4C8E-ACFB-C19028374BDE

Q26822655-0C363599-D4CA-4E88-8D9C-E21E302F5D47

Q26822655-0C54331B-10C7-4DEA-9EE1-8D44467E2270

Q26822655-0E21033D-C306-48E3-B90B-C8625CD41950

Q26822655-1075D212-DABB-45A3-AC04-3B42A878C6D5

Q26822655-14C9FD34-A500-4FE1-8210-73A29978182C

Q26822655-15FF9669-3C6F-4E77-A2C2-7EFC1433EF00

P304

Q26822655-A2CF63B8-716F-4C85-B761-D6B8B76A70C8

P31

Q26822655-79BE9DC2-18C7-414D-93FF-1BE8C77C23EA

P3181

Q26822655-95590C53-84C3-4525-8C43-F14BFB3A5FE1

P407

Q26822655-E9EB6A5D-71B1-46AF-B272-3AB463AB0DFA

P433

Q26822655-F82AE5BC-3E32-4870-8030-A8B11D4EB3F9

P478

Q26822655-10331534-49D8-4A95-B735-8AA7268173AF

P577

Q26822655-0B3BA619-6FFA-40EF-B8AA-D6ABBC01A51D

P698

Q26822655-E019A62D-5753-4172-B572-D2B69BB7231F

P921

Q26822655-B6854CD3-127D-4987-B125-F151364EE59E

P932

Q26822655-866D0757-ABE7-4159-B464-86A6331C823E

P3181

P1433

International Journal of Preventive Medicine

P1476

Atherosclerosis: process, indicators, risk factors and new hopes

@en

P2093

Azar Baradaran

http://www.w3.org/2001/XMLSchema#string

Hamid Nasri

http://www.w3.org/2001/XMLSchema#string

Mahbubeh Setorki

http://www.w3.org/2001/XMLSchema#string

Mahmoud Rafieian-Kopaei

http://www.w3.org/2001/XMLSchema#string

Monir Doudi

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidants, antioxidants, and the degenerative diseases of aging

Atherosclerosis — An Inflammatory Disease

What nephrolopathologists need to know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions?

Catastrophic antiphospholipid syndrome: a clinical review

Vascular endothelial cells synthesize nitric oxide from L-arginine

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

Blood pressure, stroke, and coronary heart disease

The pathogenesis of atherosclerosis: a perspective for the 1990s

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

Turmeric: Reemerging of a neglected Asian traditional remedy.

P304

927-946

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2137666

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25489440

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4258672

http://www.w3.org/2001/XMLSchema#string